We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+28.4%
3 Year Est. Return
+87.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$35.4M
Cap. Flow
+$24.2M
Cap. Flow %
2.02%
Top 10 Hldgs %
40.48%
Holding
693
New
31
Increased
121
Reduced
186
Closed
47

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$37.7M
2
XYL icon
Xylem
XYL
+$6.33M
3
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$3.46M
4
ARE icon
Alexandria Real Estate Equities
ARE
+$2.97M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.71M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$6.33M
2
PANW icon
Palo Alto Networks
PANW
+$1.41M
3
AMTM
Amentum Holdings
AMTM
+$1.24M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.14M
5
PWR icon
Quanta Services
PWR
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 19.09%
2 Healthcare 13.25%
3 Communication Services 12.74%
4 Industrials 12.57%
5 Consumer Discretionary 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JANX icon
626
Janux Therapeutics
JANX
$912M
$1.55K ﹤0.01%
+29
New +$1.53K
CGEM icon
627
Cullinan Oncology
CGEM
$1.06B
$1.55K ﹤0.01%
127
– –
FERG icon
628
Ferguson
FERG
$43.9B
$1.49K ﹤0.01%
9
-18
-67% -$3.58K
TWST icon
629
Twist Bioscience
TWST
$5.32B
$1.49K ﹤0.01%
32
– –
NRDY icon
630
Nerdy
NRDY
$108M
$1.48K ﹤0.01%
913
– –
MRNA icon
631
Moderna
MRNA
$21.6B
$1.46K ﹤0.01%
35
– –
SNDX icon
632
Syndax Pharmaceuticals
SNDX
$1.7B
$1.42K ﹤0.01%
107
– –
CGON icon
633
CG Oncology
CGON
$6.1B
$1.41K ﹤0.01%
49
– –
ABEV icon
634
Ambev
ABEV
$47.9B
$1.38K ﹤0.01%
745
+173
+30% +$383
STX icon
635
Seagate
STX
$173B
$1.29K ﹤0.01%
15
-107
-88% -$10.8K
LUNG icon
636
Pulmonx
LUNG
$52.8M
$1.13K ﹤0.01%
167
– –
GPCR icon
637
Structure Therapeutics
GPCR
$3.37B
$1.11K ﹤0.01%
41
– –
KURA icon
638
Kura Oncology
KURA
$793M
$1K ﹤0.01%
115
– –
BTAI icon
639
BioXcel Therapeutics
BTAI
$24.8M
$962 ﹤0.01%
161
– –
PLRX icon
640
Pliant Therapeutics
PLRX
$65M
$856 ﹤0.01%
65
– –
CYRX icon
641
CryoPort
CYRX
$753M
$545 ﹤0.01%
70
– –
GMAB icon
642
Genmab
GMAB
$17.5B
$417 ﹤0.01%
+20
New +$439
TLK icon
643
Telkom Indonesia
TLK
$14.2B
$263 ﹤0.01%
16
-63
-80% -$1.1K
EMBC icon
644
Embecta
EMBC
$218M
$103 ﹤0.01%
5
– –
SPCE icon
645
Virgin Galactic
SPCE
$315M
$29 ﹤0.01%
5
– –
OPTT icon
646
Ocean Power Technologies
OPTT
$41.5M
$1 ﹤0.01%
1
– –
ABNB icon
647
Airbnb
ABNB
$90.8B
– –
-54
Closed -$7.27K
ARES icon
648
Ares Management
ARES
$28.1B
– –
-51
Closed -$8.7K
ASML icon
649
ASML
ASML
$596B
– –
-53
Closed -$43.8K
BIIB icon
650
Biogen
BIIB
$30.9B
– –
-134
Closed -$26K
24 25
26
27 28

Similar funds

VHAM
Van Hulzen Asset Management El Dorado Hills, California $1.35B AUM 22.73% 1-Year Est. Return
ME
McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return
HAM
HoldCo Asset Management Fort Lauderdale, Florida $1.34B AUM 28.06% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
FFW
Fusion Family Wealth Woodbury, New York $1.34B AUM 18.88% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Washington Trust Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Washington Trust Advisors held 693 positions worth $1.2B, up 3.1% from $1.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Washington Trust Advisors's Q4 2024 filing shows 31 new, 121 increased, 186 reduced and 47 closed positions. Its largest new stake was Berkshire Hathaway Class A: 5 shares worth $3.4M. The largest sale was Aptiv, an estimated $6.33M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.

  • Washington Trust Advisors's largest Q4 2024 buy was Berkshire Hathaway Class A: 5 shares worth $3.4M.
  • Washington Trust Advisors added most to Berkshire Hathaway Class B in Q4 2024, an estimated $37.7M increase.
  • Washington Trust Advisors's biggest Q4 2024 reduction was Aptiv, cutting an estimated $6.33M.
  • Washington Trust Advisors fully exited Vanguard Short-Term Bond ETF in Q4 2024, selling an estimated $501K.
  • Washington Trust Advisors's ten largest holdings make up 40% of its $1.2B portfolio in Q4 2024.
  • Washington Trust Advisors opened 31 new positions and closed 47 in Q4 2024.
  • Washington Trust Advisors's portfolio value rose 3.1% quarter-over-quarter to $1.2B.

Based on Washington Trust Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.